Full Fed. Circ. Won't Look At Patents For Withholding Meds
The Federal Circuit on Tuesday said it won't reconsider its decision to invalidate five Mallinckrodt patents covering a treatment that calls for withholding the respiratory drug Inomax from certain people. ...To view the full article, register now.
Already a subscriber? Click here to view full article